Evolva launches L-arabinose as “sugar blocker,” supporting blood sugar levels and weight

Related Articles

FormattedPicture

BUSINESS NEWS

Swiss-based biotech company Evolva has released its Q3 results, announcing it has tripled its revenue with a 250% increase in comparison to the third quarter of 2021.... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

UK prime minister Liz Truss faces mounting pressure not to scrap the sugar tax on soft drinks, which has been in force for several years, and keep healthy food... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

This week in nutrition news, Odyssey Snacks prioritized gut health within the protein bar space with its latest launch and MegaFood unveiled a line of digestive health... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

German-based Cellavent Ingredients is entering the fermented botanical space with a new organic turmeric touted to offer a wide range of benefits for gut health,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The US National Institute of Health is set to review its Draft Strategy Plan 2022 – 2026 on dietary supplements after the consultation period has ended. Its top... Read More

trans